Daily non-political popular news in brief.

REMICADE-treated patients experienced substantial improvement in psoriasis in critical body regions

Data from an integrated analysis of three randomized, placebo-controlled trials showed patients with moderate to severe psoriasis receiving REMICADE achieved a consistently high level of skin clearance in the head, trunk, lower and upper extremities as measured by the Psoriasis Area Severity Index. At week 10 of the analysis, 71 percent and 79 percent of patients receiving REMICADE 3 mg/kg or 5 mg/kg, respectively, achieved a at least a 75 percent improvement in psoriasis.

Read more »

Keywords: remicade-treated, patients, experienced, substantial, improvement, psoriasis, critical, body, regions, remicade, treated, patient, psoriasi, region

« Previous | Next »

Similar news on "REMICADE-treated patients experienced substantial improvement in psoriasis in critical body regions":

1. 1-year results of bronchial thermoplasty in refractory asthma
   02-11-2008 · EurekAlert!
   Data from the Research in Severe Asthma trial of bronchial thermoplasty published in the American Journal of Respiratory and Critical Care Medicine show that patients experienced long term improvement in pulmonary function, improved quality of life and asthma control, and a reduction in rescue medication use for patients treated with bronchial thermoplasty.
   Similar news · Read more »
   
2. Remicade data in ankylosing spondylitis show improvement in spinal mobility and spinal inflammation
   06-15-2007 · EurekAlert!
   Data presented today at the European League Against Rheumatism Annual European Congress of Rheumatology showed that patients with ankylosing spondylitis who received Remicade over two years experienced significant improvement in spinal mobility. In addition, Remicade-treated patients showed sustained reductions in spinal inflammation through two years as detected by magnetic resonance imaging.
   Similar news · Read more »
   
3. Remicade therapy shown to improve productivity in patients treated for chronic plaque psoriasis
   02-02-2007 · EurekAlert!
   Investigators reported today at the American Academy of Dermatology annual meeting that patients with moderate to severe plaque psoriasis receiving Remicade (infliximab) induction and maintenance therapy experienced significant improvements in productivity at week 10, which were sustained through week 50.
   Similar news · Read more »
   
4. New analyses reinforce efficacy of Remicade in treatment of severe psoriasis
   02-02-2007 · EurekAlert!
   Findings from an integrated analysis of data from three pivotal, randomized, placebo-controlled trials showed that at week 10 more than three-quarters of patients with severe psoriasis receiving Remicade (infliximab) 3 mg/kg or 5 mg/kg achieved a 75 percent improvement in the chronic, inflammatory skin disease as measured by the Psoriasis Area Severity Index (PASI 75).
   Similar news · Read more »
   
5. Acute lung injury patients one-third less likely to die in 'closed' model ICUs
   09-28-2007 · EurekAlert!
   Patients with acute lung injury are nearly one-third less likely to die if they are treated at ICUs that require board-certified critical care physicians to oversee patient care, as compared to patients treated at ICUs that allow any attending physician to oversee admission and case management.
   Similar news · Read more »
   
6. Monoclonal Antibody Reduces Exacerbations In Asthmatics, Study Finds
   10-10-2006 · ScienceDaily
   Patients with symptomatic moderate asthma who were treated with anti-tumor necrosis factor alpha, an anti-inflammatory monoclonal antibody, experienced significantly fewer disease exacerbations than individuals taking a placebo. This research appears in the first issue for October 2006 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.
   Similar news · Read more »
   
7. Research shows survival benefit for leukemia patients treated with arsenic trioxide
   06-04-2007 · EurekAlert!
   Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
   Similar news · Read more »
   
8. MSF reports major increase in visceral leishmaniasis in war-torn Somalia
   10-30-2007 · EurekAlert!
   Marie-Eve Raguenaud and colleagues analyzed data on 1,671 patients with visceral leishmaniasis admitted to the Huddur health center in Bakool Region, Somalia, from January 2002 until December 2006. "The experience suggests that VL is substantially underreported in Bakool region and possibly in neighboring regions of southern Somalia," the researchers say.
   Similar news · Read more »
   
9. Social support improves mental health after a traumatic health care intervention
   10-15-2006 · EurekAlert!
   Support from hospital staff and family is an important factor in preventing post-traumatic stress disorder after a major intensive-care intervention. A study published today in the open access journal Critical Care reveals that patients who were successfully treated for severe acute respiratory distress syndrome (ARDS) are less likely to report symptoms of post-traumatic stress disorder (PTSD) if they feel that they were supported during and after the intervention in the Intensive Care Unit.
   Similar news · Read more »
   
10. Medical teams are key to patient safety
    12-28-2006 · EurekAlert!
    Medical teams -- not individuals -- are critical to the prevention of catheter-related bloodstream infections, as well as for the overall health, safety, and welfare of patients, according to an editorial by two Virginia Commonwealth University physicians published in today's issue of the New England Journal of Medicine.
    Similar news · Read more »